Hyalgan® has a dose-dependent differential effect on macrophage proliferation and cell death

Journal of Orthopaedic Research

Volumn 21, Issue 4, 2003, Pages 744-751

  Sheehan, Kyle M ^a   DeLott, Lindsey B ^a   Day, Susan M ^b   DeHeer, David H ^a  

^a CALVIN COLLEGE   (United States)

^b GROSRP   (United States)

Author keywords

Apoptosis; Hyalgan ; Hyaluronic acid; Macrophage; Osteoarthritis; Proliferation

Indexed keywords

BIOCHEMISTRY; MOLECULAR WEIGHT; ORGANIC ACIDS;

OSTEOARTHRITIS;

CELLS;

HYALURONIC ACID; CELL SURFACE RECEPTOR; IMMUNOLOGICAL ADJUVANT;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL GROWTH; CELL LINE; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE FUNCTION; MOLECULAR WEIGHT; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; ARTICLE; CELL DIVISION; CELL STRAIN U937; CYTOLOGY; DRUG EFFECT; MACROPHAGE; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYALURONIC ACID; MACROPHAGES; RECEPTORS, CELL SURFACE; U937 CELLS;

EID: 0038207019     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00007-X     Document Type: Review

References (43)

1. Adams ME, Lussier AJ, Peyron JG. A risk-benefit assessment of injections of hyaluronan and its derivatives in treatment of osteoarthritis of the knee. Drug Safety 2002;23:115-30.
2. Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando T. In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions 1993;38: 122-5.
3. Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg 2001;59:613-8.
4. Altman RD. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin Arthritis Rheum 2000;30:11-8.
5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
6. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993;(Suppl 39):3-9.
7. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-76.
8. Bartkowiak D, Högner S, Baust H, Nothdurft W, Röttinger EM. Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate. Cytometry 1999;37:191-6.
9. Bertuzzi A, Del Grosso N, Gandolfi A, Sinisgalli C, Starace G. Cell cycle analysis by the relative movement approach: effect of variability across S-phase of DNA synthesis rate. Cell Prolif 1995;28:107-20.
10. Brandt KD, Smith GNJ, Simon LS. Intra-articular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000;43:1192-203.
11. Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002;99:290-9.
12. Dübe B, Lüke HJ, Aumailley M, Prehm P. Hyaluronan reduces migration and proliferation in CHO cells. Biochim Biophys Acta 2001;1538:283-9.
13. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. J Immunol 1980;40:435-46.
14. Fujii K, Fujii Y, Hubscher S, Tanaka Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 2001;167:1198-203.
15. Goldberg RL, Toole BP. Hyaluronate inhibition of cell proliferation. Arthritis Rheum 1987;30:769-78.
16. Green AM, Steinmetz ND. Monitoring apoptosis in real time. Cancer J 2002;8:82-92.
17. Henke C, Bitterman P, Roongta U, Ingbar D, Polunovsky V. Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am J Pathol 1996;149:1639-50.
18. Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Visual Sci 1993; 34:2313-5.
19. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-8.
20. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975;66:188-93.
21. Lepperdinger G, Müllegger J, Kreil G. Hya12-less active, but more versatile? Matrix Biol 2001;20:509-14.
22. Lindenhayn K, Heilmann HH, Niederhausen T, Walther HU, Pohlenz K. Elimination of tritium-labelled hyaluronic acid from normal and osteoarthritic rabbit knee joints. Eur J Clin Chem Clin Biochem 1997;35:355-63.
23. Lisignoli G, Grassi F, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan. Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 2001;44:1800-7.
24. Lohmander LS, Dalén N, et al. Intra-articular hyaluronan injections in the treatment or osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996;55:424-31.
25. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Meth 2000;243:147-54.
26. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
27. Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993;13:441-6.
28. Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta 1997; 1362:221-31.
29. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002;162:292-8.
30. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol 1974;22:731-6.
31. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905-15.
32. Rigby WF, Shen L, Ball ED, Guyre PM, Fanger MW. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood 1984;64:1110-5.
33. Sattar A, Kumar S, West DC. Does hyaluronan have a role in endothelial cell proliferation of the synovium? Semin Arthritis Rheum 1992;22:37-43.
34. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol 1995;147:229-37.
35. Shibata Y, Midorikawa K, Emoto G, Naito M. Clinical evaluation of sodium hyaluronate for the treatment of patients with rotator cuff tear. J Shoulder Elbow Surg 2001;10:209-16.
36. Suzuki Y, Yamaguchi T. Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release. Agents Actions 1993;38:32-7.
37. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000;27:1713-20.
38. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D. Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 2001;19:500-3.
39. Takazoe K, Tesch GH, Hill PA, Hurst LA, Jun Z, Lan HY, et al. CD44-mediated neutrophil apoptosis in the rat. Kidney Int 2000;58:1920-30.
40. Tanaka Y, Makiyama Y, Mitsui Y. Endothelin-1 is involved in the growth promotion of vascular smooth muscle cells by hyaluronic acid. Int J Cardiol 2000;76:39-47.
41. Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
42. Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 2000;8:277-84.
43. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-23.